BiotechTube

Hetrombopag Olamine

Phase 1UNKNOWN
1 views this week 0 watching💤 Quiet
Interest: 25/100
25
Hype Score

Development Stage

✓
Pre-clinical
2
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Chronic Idiopathic Thrombocytopenic Purpura

Conditions

Chronic Idiopathic Thrombocytopenic Purpura

Trial Timeline

Aug 1, 2015 → —

NCT ID
NCT02614846

About Hetrombopag Olamine

Hetrombopag Olamine is a phase 1 stage product being developed by Jiangsu Hengrui Medicine for Chronic Idiopathic Thrombocytopenic Purpura. The current trial status is unknown. This product is registered under clinical trial identifier NCT02614846. Target conditions include Chronic Idiopathic Thrombocytopenic Purpura.

What happened to similar drugs?

20 of 20 similar drugs in Chronic Idiopathic Thrombocytopenic Purpura were approved

Approved (20) Terminated (3) Active (0)
✅Pegasys® + Pegasys®Chugai PharmaceuticalApproved
✅Telmisartan/Rosuvastatin 40/10mg + Telmisartan 40mgYuhanApproved
✅placebo + aspirin + clopidogrel + aspirin OR prasugrel + aspirinDaiichi SankyoApproved
✅alefacept + polyvalent pneumococcal vaccineAstellas PharmaApproved
✅alefaceptAstellas PharmaApproved
✅AlefaceptAstellas PharmaApproved
✅lysozyme 90 mg + PlaceboEisaiApproved

Hype Score Breakdown

Clinical
6
Activity
4
Company
15
Novelty
0
Community
0

Clinical Trials (7)

NCT IDPhaseStatus
NCT05944211Phase 2Recruiting
NCT03977805Phase 1Completed
NCT03603132Phase 1Completed
NCT03557099Phase 1/2Completed
NCT02614846Phase 1UNKNOWN
NCT02403440Phase 1UNKNOWN
NCT02409394Phase 1Completed

Competing Products

20 competing products in Chronic Idiopathic Thrombocytopenic Purpura

See all competitors
ProductCompanyStageHype Score
Levofloxacin 500Dr. Reddy's LaboratoriesPre-clinical
23
mRNA-0184ModernaPhase 1
0
Lubiprostone + Lubiprostone + PlaceboDr. Reddy's LaboratoriesPhase 3
37
macitentan 10 mgBML, Inc.Phase 3
32
KPL-716 + PlaceboKiniksa PharmaceuticalsPhase 2
29
TERN-701Terns PharmaceuticalsPhase 1/2
36
Fludarabine + Cyclophosphamide + PRGN-3007PrecigenPhase 1
23
LY3556050 + PlaceboEli LillyPhase 2
35
THB001Third Harmonic BioPhase 1
11
BriquilimabJasper TherapeuticsPhase 1/2
26
BriquilimabJasper TherapeuticsPhase 1/2
14
BriquilimabJasper TherapeuticsPhase 2
29
Empagliflozin + Matching placeboEli LillyPhase 3
40
LY3461767 + PlaceboEli LillyPhase 1
29
Pirtobrutinib + Venetoclax + RituximabEli LillyPhase 3
44
LY3526318 + PlaceboEli LillyPhase 2
35
PirtobrutinibEli LillyPhase 2
42
Ibrutinib + LY3214996Eli LillyPhase 1
21
Pirtobrutinib + AcalabrutinibEli LillyPhase 2
27
LYR-210Lyra TherapeuticsPhase 2
25